These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1074 related articles for article (PubMed ID: 6606675)

  • 21. Anti-C-reactive protein inhibits cytoskeletal rearrangement without altering calcium influx in natural killer cell activation.
    Khattri R; Hansen B; Nichols TC; Palmer KL; Gilman-Sachs A; Baum LL
    Cell Immunol; 1994 May; 155(2):457-75. PubMed ID: 8181076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-idiotype antibodies to the 9.1C3 blocking antibody used to probe the lethal hit stage of NK cell-mediated cytolysis.
    Werkmeister JA; Burns GF; Triglia T
    J Immunol; 1984 Sep; 133(3):1385-90. PubMed ID: 6611373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
    Perl A; Looney RJ; Ryan DH; Abraham GN
    J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single cell marker of active NK cytotoxicity: only a fraction of target binding lymphocytes are killer cells.
    Targan S; Grimm E; Bonavida B
    J Clin Lab Immunol; 1980 Nov; 4(3):165-8. PubMed ID: 7205938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rat natural killer cell and cytotoxic T cell lysis of H-2-negative murine embryonal carcinoma cells.
    Bell SM; Stern PL
    Eur J Immunol; 1985 Jan; 15(1):59-65. PubMed ID: 3155686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
    Bonavida B; Katz J; Gottlieb M
    J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human leukemia-derived cell lines and clones as models for mechanistic analysis of natural killer cell-mediated cytotoxicity.
    Zarcone D; Tilden AB; Friedman HM; Grossi CE
    Cancer Res; 1987 May; 47(10):2674-82. PubMed ID: 2436754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8.
    Perussia B; Fanning V; Trinchieri G
    J Immunol; 1983 Jul; 131(1):223-31. PubMed ID: 6408172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
    Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
    J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assignment of human natural killer (NK)-like cells to the T cell lineage. Single allospecific T cell clones lyse specific or NK-sensitive target cells via distinct recognition structures.
    Moretta A; Pantaleo G; Mingari MC; Melioli G; Moretta L; Cerottini JC
    Eur J Immunol; 1984 Feb; 14(2):121-5. PubMed ID: 6230242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reorientation of the Golgi apparatus and the microtubule-organizing center in the cytotoxic effector cell is a prerequisite in the lysis of bound target cells.
    Kupfer A; Dennert G; Singer SJ
    J Mol Cell Immunol; 1985; 2(1):37-49. PubMed ID: 3880506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism.
    Brahmi Z; Bray RA; Abrams SI
    J Immunol; 1985 Dec; 135(6):4108-13. PubMed ID: 3864859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
    Uchida A; Moore M
    J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
    Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
    Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of lymphocyte-target conjugates by flow cytometry. I. Discrimination between killer and non-killer lymphocytes bound to targets and sorting of conjugates containing one or multiple lymphocytes.
    Lebow LT; Stewart CC; Perelson AS; Bonavida B
    Nat Immun Cell Growth Regul; 1986; 5(5):221-37. PubMed ID: 3491299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of altered membrane structure on NK cell-mediated cytotoxicity. II. Conversion of NK-resistant tumor cells into NK-sensitive targets upon fusion with liposomes containing NK-sensitive membranes.
    Roozemond RC; van der Geer P; Bonavida B
    J Immunol; 1986 May; 136(10):3921-9. PubMed ID: 3701064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killer cell activity in the rat. Analysis of effector cell morphology and effects of interferon on natural killer cell function in the athymic (nude) rat.
    Reynolds CW; Timonen TT; Holden HT; Hansen CT; Herberman RB
    Eur J Immunol; 1982 Jul; 12(7):577-82. PubMed ID: 6180907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of NK cytotoxicity by antibody-C3b/iC3b heteroconjugates.
    Yefenof E; Benizri R; Reiter Y; Klein E; Fishelson Z
    J Immunol; 1990 Feb; 144(4):1538-43. PubMed ID: 2303717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.